• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-Grade Glioma.

作者信息

Jones David T W, Witt Olaf, Pfister Stefan M

机构信息

David T.W. Jones, German Cancer Research Center and Hopp Children's Cancer Center at the National Center for Tumor Diseases Heidelberg, Heidelberg, Germany; and Olaf Witt and Stefan M. Pfister, German Cancer Research Center, Hopp Children's Cancer Center at the National Center for Tumor Diseases Heidelberg, and Heidelberg University Hospital, Heidelberg, Germany.

出版信息

J Clin Oncol. 2018 Jan 1;36(1):96. doi: 10.1200/JCO.2017.75.8987. Epub 2017 Nov 15.

DOI:10.1200/JCO.2017.75.8987
PMID:29140771
Abstract
摘要

相似文献

1
BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-Grade Glioma.仅BRAF V600E状态不足以作为小儿低级别胶质瘤的预后生物标志物。
J Clin Oncol. 2018 Jan 1;36(1):96. doi: 10.1200/JCO.2017.75.8987. Epub 2017 Nov 15.
2
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.BRAF V600E在儿童低级别胶质瘤中的治疗及预后意义
J Clin Oncol. 2017 Sep 1;35(25):2934-2941. doi: 10.1200/JCO.2016.71.8726. Epub 2017 Jul 20.
3
BRAF Dimerization: An Underlying Resistance Mechanism in Low-Grade Pediatric Gliomas.
Cancer Discov. 2018 Sep;8(9):1064-1065. doi: 10.1158/2159-8290.CD-18-0784.
4
BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.BRAF突变和CDKN2A缺失定义了儿童继发性高级别胶质瘤一个临床上独特的亚组。
J Clin Oncol. 2015 Mar 20;33(9):1015-22. doi: 10.1200/JCO.2014.58.3922. Epub 2015 Feb 9.
5
Oncogenic BRAF inhibitor UAI-201 induces cell cycle arrest and autophagy in BRAF mutant glioma cells.致癌 BRAF 抑制剂 UAI-201 诱导 BRAF 突变型神经胶质瘤细胞的细胞周期停滞和自噬。
Life Sci. 2014 May 28;104(1-2):38-46. doi: 10.1016/j.lfs.2014.03.026. Epub 2014 Apr 8.
6
Diencephalic pediatric low-grade glioma harboring the BRAF V600E mutation presenting with various morphologies in sequential biopsy specimens.携带BRAF V600E突变的间脑型小儿低级别胶质瘤在连续活检标本中呈现出多种形态。
Brain Tumor Pathol. 2017 Oct;34(4):165-171. doi: 10.1007/s10014-017-0298-4. Epub 2017 Aug 23.
7
EGFR blockade prevents glioma escape from BRAFV600E targeted therapy.表皮生长因子受体（EGFR）阻断可防止胶质瘤逃避BRAFV600E靶向治疗。
Oncotarget. 2015 Sep 8;6(26):21993-2005. doi: 10.18632/oncotarget.4014.
8
A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.BRAF V600 突变的丘脑儿童低级别胶质瘤的临床病理研究。
Acta Neuropathol. 2015 Oct;130(4):575-85. doi: 10.1007/s00401-015-1467-3. Epub 2015 Aug 12.
9
[BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].250例与癫痫相关脑肿瘤中的BRAF V600E突变及临床病理特征
Zhonghua Bing Li Xue Za Zhi. 2018 Sep 8;47(9):664-670. doi: 10.3760/cma.j.issn.0529-5807.2018.09.003.
10
Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.BRAF V600E 突变型胶质瘤中 BRAF 抑制剂与放疗联合应用的生存优势。
J Neurooncol. 2016 Feb;126(3):385-93. doi: 10.1007/s11060-015-1939-2. Epub 2015 Sep 18.

引用本文的文献

1
Multimodal deep learning improves recurrence risk prediction in pediatric low-grade gliomas.多模态深度学习改善小儿低级别胶质瘤的复发风险预测。
Neuro Oncol. 2025 Jan 12;27(1):277-290. doi: 10.1093/neuonc/noae173.
2
Role of surgery in the treatment of pediatric low-grade glioma with various degrees of brain stem involvement.手术在治疗不同程度脑干受累的小儿低度神经胶质瘤中的作用。
Childs Nerv Syst. 2024 Oct;40(10):3037-3050. doi: 10.1007/s00381-024-06561-y. Epub 2024 Aug 15.
3
Dissecting the Natural Patterns of Progression and Senescence in Pediatric Low-Grade Glioma: From Cellular Mechanisms to Clinical Implications.
剖析小儿低级别胶质瘤进展和衰老的自然规律：从细胞机制到临床意义。
Cells. 2024 Jul 19;13(14):1215. doi: 10.3390/cells13141215.
4
Classification and Treatment of Pediatric Gliomas in the Molecular Era.分子时代小儿胶质瘤的分类与治疗
Children (Basel). 2021 Aug 27;8(9):739. doi: 10.3390/children8090739.
5
Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas.在小儿低级别胶质瘤的背景下重新构想毛细胞星形细胞瘤。
Neuro Oncol. 2021 Oct 1;23(10):1634-1646. doi: 10.1093/neuonc/noab138.
6
Pediatric low-grade glioma in the era of molecular diagnostics.儿童低级别胶质瘤的分子诊断时代。
Acta Neuropathol Commun. 2020 Mar 12;8(1):30. doi: 10.1186/s40478-020-00902-z.
7
Risk stratification in pediatric low-grade glioma and glioneuronal tumor treated with radiation therapy: an integrated clinicopathologic and molecular analysis.儿童低级别胶质瘤和神经胶质神经元肿瘤经放射治疗的风险分层：综合临床病理和分子分析。
Neuro Oncol. 2020 Aug 17;22(8):1203-1213. doi: 10.1093/neuonc/noaa031.
8
Prolonged Response Induced by Single Agent Vemurafenib in a Spinal Ganglioglioma: A Case Report and Review of the Literature.单药维莫非尼治疗脊髓节细胞胶质瘤的长期反应：一例报告并文献复习
Front Oncol. 2019 Mar 26;9:177. doi: 10.3389/fonc.2019.00177. eCollection 2019.
9
Genome-wide DNA methylation profiling shows molecular heterogeneity of anaplastic pleomorphic xanthoastrocytoma.全基因组 DNA 甲基化谱分析显示间变性多形性黄色星形细胞瘤的分子异质性。
Cancer Sci. 2019 Feb;110(2):828-832. doi: 10.1111/cas.13903. Epub 2019 Jan 4.
10
CDKN2A/B Loss Is Associated with Anaplastic Transformation in a Case of NTRK2 Fusion-positive Pilocytic Astrocytoma.CDKN2A/B 缺失与 NTRK2 融合阳性毛细胞星形细胞瘤中的间变转化相关。
Neuropathol Appl Neurobiol. 2019 Feb;45(2):174-178. doi: 10.1111/nan.12503. Epub 2018 Jun 21.